4 completed, 1 active not recruiting, 1 recruiting, 1 withdrawn. 3 Phase 1, 2 Phase 4, 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Recruiting 1, Withdrawn 1 |
| Phase 4 | 2 | Completed 2 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Malignant Neoplasms of Urinary Tract: new trials by email Literature Review of Malignant Neoplasms of Urinary Tract trials Research Report on Malignant Neoplasms of Urinary Tract
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT Pembrolizumab, Clostridium Novyi-NT, Doxycycline - Malignant Neoplasm of Breast, Malignant Neoplasms of Digestive Organs | Phase 1 | Completed | M.D. Anderson Cancer Center | 18 | 2018-07-10 | 2026-11-03 |
| Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma Cabozantinib, Sunitinib Malate - Malignant Neoplasms of Urinary Tract, Renal Cell Carcinoma | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 32 | 2018-05-15 | 2026-07-16 |
| Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases Gemcitabine - Malignant Neoplasm of Bone and Articular Cartilage, Malignant Neoplasms of Female Genital Organs | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 44 | 2017-11-22 | 2026-07-15 |
| Neuromuscular Blockade on Shoulder Pain of Elderly Deep Neuromuscular Blockade (NMB), Moderate Neuromuscular Blockade (NMB), Sugammadex - Malignant Neoplasms of Digestive Organs, Malignant Neoplasms of Female Genital Organs | Phase 4 | Completed | M.D. Anderson Cancer Center | 100 | 2017-11-17 | 2020-11-25 |
| Investigation of Sugammadex in Outpatient Urological Procedures Rocuronium, Sugammadex, Neostigmine - Malignant Neoplasms of Urinary Tract, Bladder Cancer | Phase 4 | Completed | M.D. Anderson Cancer Center | 54 | 2017-09-18 | 2020-09-22 |
| Oral Supplementation to Enhance Recovery Pilot Study Arginine recovery supplement, Omega-3 Fatty Acids - Malignant Neoplasms of Urinary Tract | Early Phase 1 | Completed | M.D. Anderson Cancer Center | 46 | 2017-08-16 | 2022-08-24 |
| Lenvatinib and Capecitabine in Patients With Advanced Malignancies Lenvatinib, Capecitabine - Advanced Cancer, Malignant Neoplasm of Breast | Phase 1 | Withdrawn | M.D. Anderson Cancer Center | 2016-12-01 | 2017-06-26 |
Urologic Neoplasms (7) · Breast Neoplasms (2) · Urinary Bladder Neoplasms (2) · Bone Neoplasms (1) · Carcinoma, Renal Cell (1) · Melanoma (1) · Osteosarcoma (1)
Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Male Urogenital Diseases (7) · Neoplasms (7) · Neoplasms by Site (7) · Urogenital Diseases (7) · Urogenital Neoplasms (7) · Urologic Diseases (7) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Breast Diseases (2) · Neoplasms by Histologic Type (2) · Urinary Bladder Diseases (2) · Adenocarcinoma (1) · Bone Diseases (1)
Neostigmine (2) · Sugammadex (2) · Capecitabine (1) · Doxycycline (1) · Fatty Acids, Omega-3 (1) · Gemcitabine (1) · Glycopyrrolate (1) · Rocuronium (1) · Sunitinib (1) · Surveys and Questionnaires (1) · cabozantinib (1) · lenvatinib (1) · pembrolizumab (1)
M.D. Anderson Cancer Center (7)
United States (6)
David S. Hong, MD (1) · Farzin Goravanchi, DO (1) · Matthew T Campbell (1) · Najat C. Daw-Bitar, MD (1) · Neema Navai, MD (1) · Sarina Piha-Paul, MD (1) · Sarina Piha-Paul, MD, PHD (1)